TGTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TG Therapeutics Inc (TGTX) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock demonstrates strong technical indicators, positive news sentiment, and a bullish analyst outlook, making it a solid choice for long-term growth.
The stock is in a strong bullish trend with MACD histogram at 1.129 (positively expanding), RSI_6 at 94.309 (overbought), and bullish moving averages (SMA_5 > SMA_20 > SMA_200). The current price is near the resistance level (R1: 52.537), with further resistance at R2: 55.848.
Positive study results for BRIUMVI in treating myasthenia gravis.
Increased revenue forecast for Q1 2026 ($205M) and full-year sales forecast ($925M).
Analysts' bullish sentiment with a raised price target to $70 by H.C. Wainwright.
RSI indicates overbought conditions, suggesting a potential short-term pullback.
Retail investor sentiment has shifted from 'extremely bullish' to 'bullish', which could indicate waning enthusiasm.
No detailed financial data available, but the company has forecasted strong revenue growth for Q1 2026 ($205M) and full-year 2026 ($925M).
Seven out of nine analysts rate the stock as 'Buy' or higher. H.C. Wainwright recently raised the price target to $70 from $60, citing increased confidence in the company's 2026 performance.
